Hospital advertising has grown more than five-fold in the past two decades. However, unlike detailing and advertising for prescription drugs, the topic of hospital advertising has been understudied. This research introduces a customer-centric view to this market by investigating the role of advertising in patients’ choice of high-tech medical procedures, with a focus on robotic surgery. The authors analyze approximately 140,000 individual patient records and television advertising data from Florida during 2011–2015 to investigate how hospital advertising of robotic surgery affects patients’ choice of robotic surgery over more conventional laparoscopic and open surgeries. Using a variation of a designated market area border identification strategy, the authors find that this advertising leads to more robotic surgery choices. The advertising effect is especially strong for Medicaid patients, whose socioeconomic status tends to be lower. While robotic surgery is associated with a short-term health benefit (i.e., reduced length of hospital stay), it does not affect long-term health benefits and comes at a higher cost than other forms of surgery. Thus, understanding the effect of advertising robotic surgery has significant health, cost, and marketing implications for different stakeholders in the health care industry, such as patients, health care providers, surgical robot manufacturers, insurance providers, and policy makers.
AizawaNaokiKimYou Suk (2018), “Advertising and Risk Selection in Health Insurance Markets,” American Economic Review, 108 (3), 828–67.
2.
AizawaNaokiKimYou Suk (2020), “Government Advertising in Market-Based Public Programs: Evidence from the Health Insurance Marketplace,” Working Paper 27695 National Bureau of Economic Research, DOI: 10.3386/w27695.
3.
AlpertAbbyLakdawallaDariusSoodNeeraj (2015), “Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D,” Working Paper 21714, National Bureau of Economic Research, DOI: 10.3386/w21714.
4.
AngristJoshua D.PischkeJörn-Steffen (2009), Mostly Harmless Econometrics: An Empiricist’s Companion. Princeton University Press.
5.
BakerLaurence C. (2001), “Managed Care and Technology Adoption in Health Care: Evidence from Magnetic Resonance Imaging,” Journal of Health Economics, 20 (3), 395–421.
6.
BhamaAnuradha R.ObiasVincentWelchKathleen B.VandewarkerJames F.ClearyRobert K. (2016), “A Comparison of Laparoscopic and Robotic Colorectal Surgery Outcomes Using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Database,” Surgical Endoscopy, 30 (4), 1576–84.
7.
ChanTatNarasimhanChakravarthiXieYing (2013), “Treatment Effectiveness and Side Effects: A Model of Physician Learning,” Management Science, 59 (6), 1309–25.
8.
ChildersChristopher P.Maggard-GibbonsMelinda (2018), “Estimation of the Acquisition and Operating Costs for Robotic Surgery,” JAMA, 320 (8), 835–36.
9.
ChingAndrew T. (2010), “Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs After Patent Expiration,” International Journal of Industrial Organization, 28 (6), 619–38.
10.
ChingAndrew T.IshiharaMasakazu (2012), “Measuring the Informative and Persuasive Roles of Detailing on Prescribing Decisions,” Management Science, 58 (7), 1374–87.
11.
ChintaguntaPradeep K.JiangRennaJinGinger Z. (2009), “Information, Learning, and Drug Diffusion: The Case of Cox-2 Inhibitors,” Quantitative Marketing and Economics, 7 (4), 399–443.
CutlerDavid M.McClellanMark (1996), “The Determinants of Technological Change in Heart Attack Treatment,” Working Paper 5751, National Bureau of Economic Research, DOI: 10.3386/w5751.
DubéJean-PierreHitschGünter J.ManchandaPuneet (2005), “An Empirical Model of Advertising Dynamics,” Quantitative Marketing and Economics, 3 (2), 107–44.
16.
ElixhauserAnneSteinerClaudiaHarrisD. RobertCoffeyRosanna M. (1998), “Comorbidity Measures for Use with Administrative Data,” Medical Care, 36 (1), 8–27.
17.
FDA (2019), “FDA in Brief: FDA Cautions Patients, Providers About Using Robotically-Assisted Surgical Devices for Mastectomy and Other Cancer-Related Surgeries,” press release (February 28), https://www.fda.gov/news-events/fda-brief/fda-brief-fda-cautions-patients-providers-about-using-robotically-assisted-surgical-devices.
18.
GaynorMartinPropperCarolSeilerStephan (2016), “Free to Choose? Reform and Demand Response in the English National Health Service,” American Economic Review, 106 (11), 3521–57.
19.
GoldfarbAviTuckerCatherine E. (2011), “Privacy Regulation and Online Advertising,” Management Science, 57 (1), 57–71.
20.
GuoTongSriramSrinivasaraghavanManchandaPuneet (2020), “‘Let the Sunshine In’: The Impact of Industry Payment Disclosure on Physician Prescription Behavior,” Marketing Science, 39 (3), 516–39.
21.
HartmannWesleyNairHarikesh S.NarayananSridhar (2011), “Identifying Causal Marketing Mix Effects Using a Regression Discontinuity Design,” Marketing Science, 30 (6), 1079–97.
HoskenDanielWendlingBrett (2013), “Informing the Uninformed: How Drug Advertising Affects Check-up Visits,” International Journal of Industrial Organization, 31 (2), 181–94.
24.
HuckmanRobert S.KelleyMark A. (2013), “Public Reporting, Consumerism, and Patient Empowerment,” New England Journal of Medicine, 369 (20), 1875–77.
25.
HussainAzharMalikAminaHalimMohammed U.AliAslankhani Mohammad (2014), “The Use of Robotics in Surgery: A Review,” International Journal of Clinical Practice, 68 (11), 1376–82.
26.
IavazzoChristosMamaisIoannisGkegkesIoannis D. (2016), “Robotic Assisted vs Laparoscopic and/or Open Myomectomy: Systematic Review and Meta-Analysis of the Clinical Evidence,” Archives of Gynecology and Obstetrics, 294 (1), 5–17.
27.
IizukaToshiakiJinGinger Zhe (2005), “The Effect of Prescription Drug Advertising on Doctor Visits,” Journal of Economics & Management Strategy, 14 (3), 701–27.
28.
IizukaToshiakiJinGinger Zhe (2007), “Direct to Consumer Advertising and Prescription Choice,” Journal of Industrial Economics, 55 (4), 771.
29.
ImbensGuido W.LemieuxThomas (2008), “Regression Discontinuity Designs: A Guide to Practice,” Journal of Econometrics, 142 (2), 615–35.
30.
JayneDavidPigazziAlessioMarshallHelenCroftJulieCorriganNeilCopelandJoanneQuirkePhilWestNickRautioTeroThomassenNielsTilneyHenryGudgeonMarkBianchiPaolo PietroEdlinRichardHulmeClaireBrownJulia (2017), “Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial,” JAMA, 318 (16), 1569–80.
31.
JeongIn GabKhandwalaYash S.KimJae HeonHanDeok HyunLiShufengWangYeChangSteven L.ChungBenjamin I. (2017), “Association of Robotic-Assisted vs Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Health Care Costs, 2003 to 2015,” JAMA, 318 (16), 1561–68.
32.
Karaca-MandicPinarWilcockAndrewBaumLauraBarryColleen L.FowlerErika FranklinNiederdeppeJeffGollustSarah E. (2017), “The Volume of TV Advertisements During the ACA’s First Enrollment Period Was Associated with Increased Insurance Coverage,” Health Affairs, 36 (4), 747–54.
33.
KayeDeborah R.LuckenbaughAmy N.OerlineMaryHollenbeckBrent K.HerrelLindsey A.DimickJustin B.HollingsworthJohn M. (2020), “Understanding the Costs Associated with Surgical Care Delivery in the Medicare Population,” Annals of Surgery, 271 (1), 23–28.
34.
KimTI TongilKCDiwas (2020a), “Can Viagra Advertising Make More Babies? Direct-to-Consumer Advertising on Public Health Outcomes,” Journal of Marketing Research, 57 (4), 599–616.
35.
KimTI TongilKCDiwas (2020b), “The Impact of Hospital Advertising on Patient Demand and Health Outcomes,” Marketing Science, 39 (3), 612–35.
36.
KimChang WooKimChang HeeBaikSeung Hyuk (2014), “Outcomes of Robotic-Assisted Colorectal Surgery Compared with Laparoscopic and Open Surgery: A Systematic Review,” Journal of Gastrointestinal Surgery, 18 (4), 816–30.
LiuQiangGuptaSachin (2011), “The Impact of Direct-to-Consumer Advertising of Prescription Drugs on Physician Visits and Drug Requests: Empirical Findings and Public Policy Implications,” International Journal of Research in Marketing, 28 (3), 205–17.
39.
LiuQiangSteenburghThomas J.GuptaSachin (2015), “The Cross Attributes Flexible Substitution Logit: Uncovering Category Expansion and Share Impacts of Marketing Instruments,” Marketing Science, 34 (1), 144–59.
40.
LopezSandraMullaZuber D.HernandezLorettaGarzaDevin M.PayneThomas N.FarnamRichard W. (2016), “A Comparison of Outcomes Between Robotic-Assisted, Single-Site Laparoscopy Versus Laparoendoscopic Single Site for Benign Hysterectomy,” Journal of Minimally Invasive Gynecology, 23 (1), 84–88.
41.
LuftHarold S.RobinsonJames C.GarnickDeborah W.MaerkiSusan C.McPheeStephen J. (1986), “The Role of Specialized Clinical Services in Competition Among Hospitals,” Inquiry, 23 (1), 83–94.
42.
MillerAmalia R.TuckerCatherine (2009), “Privacy Protection and Technology Diffusion: The Case of Electronic Medical Records,” Management Science, 55 (7), 1077–93.
43.
MillerAmalia R.TuckerCatherine E (2011), “Can Health Care Information Technology Save Babies?” Journal of Political Economy, 119 (2), 289–324.
44.
NarayananSridharDesirajuRamaraoChintaguntaPradeep K. (2004), “Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions,” Journal of Marketing, 68 (4), 90–105.
45.
NarayananSridharManchandaPuneet (2009), “Heterogeneous Learning and the Targeting of Marketing Communication for New Products,” Marketing Science, 28 (3), 424–41.
46.
NewhouseJoseph P. (1992), “Medical Care Costs: How Much Welfare Loss?” Journal of Economic Perspectives, 6 (3), 3–21.
47.
PaekJiheumLeeJung-DongKongTae WookChangSuk-JoonRyuHee-Sug (2016), “Robotic Single-Site Versus Laparoendoscopic Single-Site Hysterectomy: A Propensity Score Matching Study,” Surgical Endoscopy, 30 (3), 1043–50.
48.
PareekBhuvaneshLiuQiangGhoshPulak (2019), “Ask Your Doctor Whether This Product Is Right for You: A Bayesian Joint Model for Patient Drug Requests and Physician Prescriptions,” Journal of the Royal Statistical Society: Series A (Statistics in Society), 182 (1), 197–223.
49.
RaoAnitaWangEmily (2017), “Demand for ‘Healthy’ Products: False Claims and FTC Regulation,” Journal of Marketing Research, 54 (6), 968–89.
50.
RosenthalMeredith B.BerndtErnst R.DonohueJulie M.EpsteinArnold M.FrankRichard G. (2003), “Demand Effects of Recent Changes in Prescription Drug Promotion,” Forum for Health Economics & Policy, Vol. 6, David M. Cutler and Alan M. Garber, eds. De Gruyter.
51.
SchwartzLisa M.WoloshinSteven (2019), “Medical Marketing in the United States, 1997-2016,” JAMA, 321 (1), 80–96.
52.
ShapiroBradley T. (2018), “Positive Spillovers and Free Riding in Advertising of Prescription Pharmaceuticals: The Case of Antidepressants,” Journal of Political Economy, 126 (1), 381–437.
53.
ShapiroBradley T. (2020), “Advertising in Health Insurance Markets,” Marketing Science, 39 (3), 587–611.
54.
ShapiroBradley T.HitschGünter J.TuchmanAnna E. (2021), “TV Advertising Effectiveness and Profitability: Generalizable Results from 288 Brands,” Econometrica, 89 (4), 1855–79.
55.
SinkinsonMichaelStarcAmanda (2019), “Ask Your Doctor? Direct-to-Consumer Advertising of Pharmaceuticals,” Review of Economic Studies, 86 (2), 836–81.
56.
StremerschStefanLandsmanVarditVenkataramanSriram (2013), “The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space,” Marketing Science, 32 (1), 89–110.
57.
TomyczNester D. (2006), “A Profession Selling Out: Lamenting the Paradigm Shift in Physician Advertising,” Journal of Medical Ethics, 32 (1), 26–28.
58.
WosinskaMarta (2002), “Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products,” SSRN (October), https://dx.doi.org/10.2139/ssrn.347005.
59.
WosinskaMarta (2005), “Direct-to-Consumer Advertising and Drug Therapy Compliance,” Journal of Marketing Research, 42 (3), 323–32.
60.
WrightJason D.AnanthCande V.LewinSharyn N.BurkeWilliam M.LuYu-ShiangNeugutAlfred I., etal (2013), “Robotically Assisted vs Laparoscopic Hysterectomy Among Women with Benign Gynecologic Disease,” JAMA, 309 (7), 689–98.
61.
WrightJason D.BurkeWilliam M.WildeElizabeth T.LewinSharyn N.CharlesAbigail S.KimJin HeeGoldmanNoahNeugutAlfred I.HerzogThomas J.HershmanDawn L. (2012), “Comparative Effectiveness of Robotic Versus Laparoscopic Hysterectomy for Endometrial Cancer,” Journal of Clinical Oncology, 30 (8), 783–91.
62.
YoonTae Jung (2020), “Quality Information Disclosure and Patient Reallocation in the Healthcare Industry: Evidence from Cardiac Surgery Report Cards,” Marketing Science, 39 (3), 636–62.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
